Legislators in two states have resisted efforts to restrict Prescription Drug Affordability Boards, the controversial panels that are designed to function as rate-setting authorities and place limits ...

Friedrichs is a retired military medical officer whose last job in uniform was in the Pentagon as the senior medical adviser ...

Federal regulators are proposing a new, faster Medicare coverage pathway for medical devices deemed by the FDA as ...

At AACR, there was talk of Chinese biotech's place in cancer research, oncology’s comms issue, and more.

From my colleague Andrew Joseph: One of the open questions about the future of Sanofi as Belén Garijo takes over as CEO this ...

OpenAI's targets clinicians, AMA's call for regulatory crackdown, and bargain-basement telehealth visits.

President Trump is reclassifying state-licensed medical marijuana as a less-dangerous drug, a major policy shift long sought ...

Sarah Todd’s MAHA snackdown article includes such merchandising gems as “fibermaxxing” chips, “protein-powered” yogurt, and ...

Drugmakers have begun using coupons to discount the cost of telehealth visits with clinicians who can prescribe their drugs ...

The promise of a better pan-RAS inhibitor Erasca has been described as the poor man’s Revolution Medicines. Impoverished ...

Kennedy, a lawsuit challenging Kennedy’s attempts to remake the Advisory Committee on Immunization Practices. For the moment, ...

Kennedy Jr. once claimed there are no vaccines that are safe and effective. Yesterday, when a senator asked him if he ...